Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites
Links shared publicly online about this topic.
- 1,589total visits
Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM
View full resource at medicalnewstoday.com
Tags: Neurology, Autism Spectrum Disorder, Autism, Disease and Condition, Drug, Clinical Trial
Most Recently Shared on November 20, 2009 at 1:43 pm By:
Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites: Curemark LLC, a drug.. http://bit.ly/VLv9F
Also Shared By:
Advertisement
MNT Clinical Trials
@mnt_clinical
Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites: Curemark LLC, a drug.. http://bit.ly/VLv9F
1 year ago...